The retrospective review included 6 pediatric patients younger than 12 months of age in the neonatal intensive care unit.
Drugs in the Pipeline
Anecdotal reports suggest that naltrexone, an opioid antagonist, may alleviate symptoms associated with CRPS.
An evidence-based guideline for the comprehensive management of osteoarthritis , including educational, behavioral, psychosocial, and physical interventions, as well as pharmacologic therapies from the American College of Rheumatology (ACR) and the Arthritis Foundation.
Pharmacologic therapy may improve symptoms in patients with refractory overactive bladder who receive intravesical onabotulinum toxin-A injections.
Matthew Robbins, MD, author of "COVID-19 and headache: a primer for trainees," details how care has changed for patients with chronic headaches in the midst of the COVID-19 pandemic.
Features, Musculoskeletal Disorders
The American College of Rheumatology and the Arthritis Foundation developed evidence-based guidelines for the management of hand, hip, and knee osteoarthritis.
Dermatological Disorders, News
A review provides an update on current and emerging concepts of management for excessive hand sweating to help clinicians optimize therapeutic decision making.
The Food and Drug Administration (FDA) has expanded the indication of Dysport (abobotulinumtoxinA; Ipsen) to include the treatment of upper limb spasticity in patients aged 2 years and older, excluding spasticity caused by cerebral palsy. Previously, Dysport was only approved to treat lower limb spasticity in patients aged 2 years and older. The approval was…
AAN 2019 Coverage
An expert subcommittee of the AAN has released an updated evidence-based clinical practice guideline on treating Tourette syndrome and other chronic tic disorders.